Speaker illustration

Doctor Ina Bregvadze

The Center of Vascular and Heart Diseases, Tbilisi (Georgia)

Member of:

The predictors of the efficacy of pharmacological cardioversion with class III antiarrhythmic drug - nibentan in patients with persistent atrial fibrillation

Event: ESC Congress 2017

Topic: Electrocardiography

Session: Electrocardiography + cardioversion


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb